Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia
在老年和不适合接受FCR方案治疗的晚期慢性淋巴细胞白血病患者中，一线治疗方案中加入个体化剂量的来那度胺联合苯丁酸氮芥和利妥昔单抗的可行性和疗效
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2018.193854
Kater, Arnon P; van Oers, Marinus H J; van Norden, Yvette; van der Straten, Lina; Driessen, Julia; Posthuma, Ward F M; Schipperus, Martin; Chamuleau, Martine E D; Nijland, Marcel; Doorduijn, Jeanette K; Van Gelder, Michel; Hoogendoorn, Mels; De Croon, Francien; Wittebol, Shulamiet; Kerst, J Martijn; Marijt, Erik W A; Raymakers, Reinier A P; Schaafsma, Martijn R; Dobber, Johan A; Kersting, Sabina; Levin, Mark-David
